EDGAR·FLOW

Medline Inc. — Form S-1

Filed November 16, 2026 · analyzed by the Registration Agent
S-1 — Neutral significance 28/100
What the filing says
Medline Inc. (IPO: Dec 2025) is conducting a secondary offering of 60 million shares of Class A common stock by selling stockholders (Blackstone, Carlyle, H F, GIC, ADIA, and others) at $39.47/share (Nov 13, 2026 close). Company and Medline Holdings will repurchase $200 million of Class A shares and Common Units at the same price (~5.1M units at $39.47). Company receives zero proceeds from secondary offering; repurchase counts toward $1B share buyback program approved Oct 2026. Transaction conditioned on closing of offering; repurchase closing is not conditional on offering closing.
Why this rating

Secondary offering does not dilute public shareholders but reduces sponsor stakes (~2%). $200M repurchase (1.5% of $13B market cap) is modest capital return. Routine post-IPO secondary by sponsors; no operational change.

View original filing on SEC.gov ↗ MDLN · stock on Yahoo Finance ↗

See more from November 16, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.